3-Aryloxymethyl-cephalosporin derivatives, their preparation and their medical use
申请人:Sankyo Company Limited
公开号:EP0363223A2
公开(公告)日:1990-04-11
Compounds of formula (I);
[in which: R¹ is hydrogen or acyl; R² is hydrogen or C₁ - C₄ alkoxy; and Ar is phenyl or substituted phenyl] and pharmaceutically acceptable salts and esters thereof have valuable antibiotic activity, including against Methicillin-resistant strains of Staphylococcus. The invention also provides a process for preparing the compounds and methods and compositions using them.
Rhizoxin derivates and their use as anti-tumor agents
申请人:SANKYO COMPANY LIMITED
公开号:EP0350315B1
公开(公告)日:1993-06-16
Process for hydrogenation of conjugated diene polymer
申请人:——
公开号:US20040082727A1
公开(公告)日:2004-04-29
A process for hydrogenation of a conjugated diene polymer. The conjugated diene polymer in an inert organic solvent is brought into contact with hydrogen in the presence of a hydrogenation catalyst composition to selectively hydrogenate the unsaturated double bonds in the conjugated diene units of the conjugated diene polymer. The hydrogenation catalyst composition includes: (I) a titanium compound; (II) a compound represented by formula (II):
1
wherein L is a Group IVB element, R is C
1
-C
12
alkyl or C
1
-C
12
cycloalkyl, X can be the same or different and is C
1
-C
12
alkyl, C
1
-C
12
alkoxy, C
1
-C
12
cycloalkoxy, halogen, or carbonyl; and (III) a trialkylaluminum compound.
Hydrogenation catalyst composition and process for hydrogenation of conjugated diene polymer
申请人:Lin Fu
公开号:US20060041079A1
公开(公告)日:2006-02-23
A process for hydrogenation of an unsaturated polymer. The conjugated diene polymer in an inert organic solvent is brought into contact with hydrogen in the presence of a hydrogenation catalyst composition to selectively hydrogenate the unsaturated double bonds in the conjugated diene units of the conjugated diene polymer. The hydrogenation catalyst composition includes: (a) a titanium compound; (b) a compound represented by formula (II) or formula (III):
wherein L
1
is a Group IVA element, L
2
is a Group IVA element, R
3
is C
1
-C
12
alkyl or C
1
-C
12
cycloalkyl, R
4
is C
2
-C
12
alkyl or C
3
-C
12
cycloalkyl, and X
1
, X
2
, and X
3
can be the same or different and are C
1
-C
12
alkyl, C
1
-C
12
alkoxy, C
1
-C
12
cycloalkoxy, phenyl, or phenoxy; and (c) a trialkylaluminum compound.